#76
|
||||
|
||||
МЕЖДУНАРОДНАЯ КЛАССИФИКАЦИЯ ОРОФАЦИАЛЬНОЙ БОЛИ
Международная классификация орофациальной боли на русском языке
|
#77
|
||||
|
||||
СИНДРОМ БЕСПОКОЙНЫХ НОГ
[Ссылки доступны только зарегистрированным пользователям ]
__________________
С уважением, Юлия Александровна |
#78
|
|||
|
|||
[Ссылки доступны только зарегистрированным пользователям ]
Results: Comparing treatment of 596 with IVF to 905 with SoC resulted in an ATE to achieve the primary outcome of 9.3%[95%CI4.4-14.1]. IVF treatment showed a significant shift towards improved outcome across the entire range of mRS estimates, common-OR:1.75[95%CI1.39-2.17], reduced mortality, OR:0.47[95%CI 0.35-0.64], without increased adverse events, absolute difference:1.0%[95%CI-2.7-4.8]. Exploratory analyses provided that early IVF-treatment (≤48 hours) after symptom onset was associated with an ATE:15.2%[95%CI8.6-21.8] to achieve the primary outcome.
__________________
Филиппов Павел Геннадьевич. |
#79
|
||||
|
||||
МЕЖДУНАРОДНАЯ КЛАССИФИКАЦИЯ ГОЛОВНОЙ БОЛИ - 3. НА РУССКОМ ЯЗЫКЕ.
__________________
С уважением, Юлия Александровна |
#80
|
|||
|
|||
[Ссылки доступны только зарегистрированным пользователям ]
__________________
Филиппов Павел Геннадьевич. |
#81
|
|||
|
|||
[Ссылки доступны только зарегистрированным пользователям ]
__________________
Филиппов Павел Геннадьевич. |
#82
|
|||
|
|||
[Ссылки доступны только зарегистрированным пользователям ]
__________________
Филиппов Павел Геннадьевич. |
#83
|
||||
|
||||
Patients orally took capsules containing either vitamin K2 (menaquinone 7), 180 μg, or a similar-looking placebo every day for 8 weeks.
Of the 199 enrolled individuals, 108 (54.3%) were female, and the mean (SD) age was 72.3 (5.5) years. A total of 103 patients (51.8%) were randomly assigned to receive vitamin K2 and 96 (48.2%) were assigned to placebo. The mean (SD) baseline weekly frequency of cramps was comparable in both the vitamin K2 group (2.60 [0.81]) and the placebo group (2.71 [0.80]). During the 8-week intervention, the vitamin K2 group experienced a reduction in the mean (SD) weekly frequency of cramps to 0.96 (1.41). Meanwhile, the placebo group maintained mean (SD) weekly frequency of cramps at 3.63 (2.20). The between-group difference was statistically significant (difference, −2.67; 95% CI, −2.86 to −2.49; P < .001). The vitamin K2 group had a more significant mean (SD) reduction in NLC severity (−2.55 [2.12] points) compared with the placebo group (−1.24 [1.16] points). The vitamin K2 group exhibited a more pronounced mean (SD) decrease in the duration of NLCs (−0.90 [0.88] minutes) than the placebo group (−0.32 [0.78] minutes). No adverse events related to vitamin K2 use were identified. Vitamin K2 in Managing Nocturnal Leg Cramps A Randomized Clinical Trial [Ссылки доступны только зарегистрированным пользователям ]
__________________
Искренне, Вадим Валерьевич. |